BCAS4 CLIA Kit

Produktnummer ABIN6225925

Dieses Chemiluminescent ELISA-Kit wurde entwickelt für die quantitative Messung von Human BCAS4.

Kurzübersicht für BCAS4 CLIA Kit (ABIN6225925)

Target: BCAS4 (Breast Carcinoma Amplified Sequence 4 (BCAS4))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.156 ng/mL - 10 ng/mL

Applikation: ELISA

Proben: Cell Lysate, Tissue Homogenate

Produktdetails BCAS4 CLIA Kit

Untere Nachweisgrenze: 0.156 ng/mL

Verwendungszweck: Breast Carcinoma Amplified Sequence 4 CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates and other biological fluids.

Analytische Methode: Quantitative

Sensitivität: < 0.055 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: BCAS4 (Breast Carcinoma Amplified Sequence 4 (BCAS4))

Andere Bezeichnung: Breast Carcinoma Amplified Sequence 4